3,5-二溴-2-羟基-6-甲基嘧啶 | 500587-45-1

• 物质功能分类: 医药中间体 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3,5-二溴-2-羟基-6-甲基嘧啶
• 英文名称: 3,5-dibromo-2-hydroxy-6-methylpyridine
• 英文别名: 3,5-dibromo-6-methylpyridin-2-ol；3,5-dibromo-6-methyl-pyridin-2-ol；3,5-Dibrom-6-methyl-pyridin-2-ol；3,5-dibromo-6-methyl-1H-pyridin-2-one
• CAS: 500587-45-1
• 化学式: C₆H₅Br₂NO
• 分子量: 266.92
• InChiKey: KOBUELJRZDJHTE-UHFFFAOYSA-N

物化性质

• 熔点：
  254-255 °C(Solv: benzene (71-43-2); ethanol, 95% (64-17-5))
• 沸点：
  289.9±40.0 °C(Predicted)
• 密度：
  2.081±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3,5-Dibromo-2-hydroxy-6-methylpyridine
Synonyms: 3,5-Dibromo-6-methylpyridin-2-ol

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3,5-Dibromo-2-hydroxy-6-methylpyridine
CAS number: 500587-45-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H5Br2NO
Molecular weight: 266.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3,5-二溴-2-羟基-6-甲基嘧啶 在 正丁基锂 、 硝酸 、 三氯氧磷 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 13.0h， 生成 3-溴-2-氯-5-硝基-6-甲基吡啶
  参考文献：
  名称：

  [EN] INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
  [FR] INHIBITEURS DE LA DÉMÉTHYLASE 1 SPÉCIFIQUE DE LA LYSINE

  摘要：

  本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本文提供了替代杂环衍生物化合物和包含该化合物的药物组合物。所述化合物和组合物对于抑制赖氨酸特异性去甲基化酶-1是有用的。此外，所述化合物和组合物对于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等是有用的。

  公开号：

  WO2016037005A1
• 作为产物：
  描述：

  2-氨基-6-甲基吡啶 在 硫酸 、 溴 、 sodium nitrite 作用下， 生成 3,5-二溴-2-羟基-6-甲基嘧啶
  参考文献：
  名称：

  Adams; Schrecker, Journal of the American Chemical Society, 1949, vol. 71, p. 1186,1191

  摘要：

  DOI：

文献信息

• [EN] HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES HÉTÉROARYLES ET LEURS UTILISATIONS
  申请人：HUTCHISON MEDIPHARMA LTD

  公开号：WO2021164735A1

  公开（公告）日：2021-08-26

  Provided herein are heteroaryl heterocyclic compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the variables are as defined in the description.

  本文提供了公式（I）的杂环杂芳基化合物，包括这些化合物的药物组合物，制备这些化合物的方法以及它们的用途，其中变量如描述中所定义。
• [EN] INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1<br/>[FR] INHIBITEUR DE LA DÉMÉTHYLASE-1 SPÉCIFIQUE DE LA LYSINE
  申请人：QUANTICEL PHARMACEUTICALS INC

  公开号：WO2015089192A1

  公开（公告）日：2015-06-18

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本文提供了替代杂环衍生物化合物和包含该化合物的药物组合物。所述化合物和组合物对于抑制赖氨酸特异性去甲基化酶-1是有用的。此外，所述化合物和组合物对于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等是有用的。
• Efficient Regioselective Preparationof Monobromo and Bromoiodo Hydroxy Pyridines from Dibromoderivativesvia Bromine-Lithium Exchange
  作者：Mª Ascensión Sanz-Tejedor、Ángela Meana、Justo F. Rodríguez、José L. García-Ruano

  DOI：10.1055/s-2003-41013

  日期：——

  Annular dibromination of hydroxypyridines with NBS in acetonitrilefollowed by bromine-lithium exchange with RLi and subsequent trappingwith H2O or I2 afforded monobromo and bromoiododerivatives in a completely regioselective way. Iodination of bromohydroxypyridines with NIS is totally regioselective.

  氢氧嘧啶的环状二溴化反应采用NBS在乙腈中进行，随后与RLi进行溴锂交换，最后用H2O或I2捕获，完全区域选择性地得到了单溴和溴碘衍生物。用NIS对溴氢氧嘧啶进行碘化反应也是完全区域选择性的。
• Protecting Group‐Controlled Regioselective Synthesis for Unsymmetrical 3,5‐Disubstituted Pyridones
  作者：Yong‐Ju Kwon、Won‐Suk Kim

  DOI：10.1002/adsc.202101514

  日期：2022.4.12

  excellent regioselectivity. A one-pot synthesis of unsymmetrical 3,5-diaryl-2-pyridones starting from 3,5-dibromo-2-silyloxypyridine was conducted to demonstrate the practical convenience. Further functionalization onto the remaining bromine group, such as transition metal-catalyzed C−C and C−N bond-forming reactions and retro-Brook rearrangement for C−Si bond formation, was accomplished for synthesis of

  已经研究了保护基团控制的 3,5-二溴-2-吡啶酮的区域选择性功能化以制备不对称的 3,5-二取代 2-吡啶酮。Suzuki-Miyaura 反应中使用庞大的二叔丁基（异丁基）甲硅烷基 (BIBS) 基团进行 C5 区域选择性芳基化。同时，p-甲苯磺酰基 (Ts) 基团用于最大化 C3 选择性卤素-锂交换，采用流动化学。大部分反应进行得很好，产率在 76% 到 95% 之间，具有优异的区域选择性。以 3,5-二溴-2-甲硅烷氧基吡啶为原料，对不对称 3,5-二芳基-2-吡啶酮进行一锅合成，以证明其实用性。对剩余溴基团的进一步功能化，例如过渡金属催化的 C-C 和 C-N 键形成反应和用于 C-Si 键形成的逆布鲁克重排，用于合成生物学相关的 3,5-二取代 2 -吡啶酮。最后，通常用于充血性心力衰竭的氨力农和米力农由 3,5-二溴-2-吡啶酮分三步合成，总收率分别为 41% 和 56%。
• HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS
  申请人：Genentech, Inc.

  公开号：US20140378432A1

  公开（公告）日：2014-12-25

  Heteroaryl pyridone and aza-pyridone compounds are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using heteroaryl pyridone and aza-pyridone compounds for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

  提供了杂环芳基吡啶酮和氮杂芳基吡啶酮化合物，包括立体异构体、互变异构体和其药学上可接受的盐，用于抑制Btk激酶，并用于治疗由Btk激酶介导的免疫紊乱，如炎症。公开了使用杂环芳基吡啶酮和氮杂芳基吡啶酮化合物在哺乳动物细胞中进行体外、体内和原位诊断以及治疗此类疾病或相关病理条件的方法。